Home > PS Ratio > ABBOTT INDIA

ABBOTT INDIA
PS (Price/Sales) Ratio

The Current P/S Ratio of ABBOTT INDIA is 10.39.

Share Price ₹30,583.2Mar 27,2025
Market Cap ₹64,836.4 Cr
Sales-TTM₹6,243.2 CrTTM-Standalone Results
Price/Sales10.39xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ABBOTT INDIA
Please provide your vote to see the results
ABBOTT INDIA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ABBOTT INDIA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ABBOTT INDIA is calculated as :

Current Market Cap [ ₹64,836.4 Cr] as on Mar 27,2025

(/) Sales [ ₹6,243.2 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 10.39x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ABBOTT INDIA , the investors are currently willing to pay '10.39 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ABBOTT INDIA !

The chart below summarizes the trend in P/S Ratio of ABBOTT INDIA over the last five years.

Historical PS (Price/Sales) ratio chart of ABBOTT INDIA


PS Ratio Performance Analysis for ABBOTT INDIA

- ABBOTT INDIA 's latest p/e ratio is 10.39x.

- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.32x.

- ABBOTT INDIA 's operated at median p/e ratio of 8.02x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2024 at 9.79x.

- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 7.39x.


How does ABBOTT INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ABBOTT INDIA 6,243.210.3964,836.4
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.58.05415,373.0
DIVIS LABORATORIES LTD9,078.017.12155,437.0
CIPLA LTD26,981.24.44119,770.0
TORRENT PHARMACEUTICALS LTD11,302.09.66109,188.0
DR REDDYS LABORATORIES LTD31,229.33.1196,992.9
MANKIND PHARMA LTD11,641.08.73101,622.0
ZYDUS LIFESCIENCES LTD22,247.44.0389,660.5
LUPIN LTD22,001.64.1992,189.6
AUROBINDO PHARMA LTD30,921.82.1967,738.9
ALKEM LABORATORIES LTD12,756.64.6559,324.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ABBOTT INDIA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.19x
Max industry PS 17.12x
Median industry PS 4.65x
Average industry PS 6.96x



You may also like the below Video Courses